FCX three-lens brief
Evidence-based stock research on FCX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $70.84 — 16% above current (22 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $70.84 — 16% above current (22 analysts).
- Earnings scheduled 2026-07-22.
- Ex-dividend date 2026-07-15.
FCX closed at $61.20 (+1.11%) as of 2026-07-10. Market cap: $87.98B. P/E (trailing) 32.4. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $70.84 — 16% above current (22 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $6.23B, net income $881.00M, free cash flow $1.71B. Watching for: 2026-07-22 earnings release (11 days out).
Why three lenses on FCX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine FCXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/FCX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath FCX brief"></iframe>